Download PDF
Thromb Haemost 1983; 50(03): 669-670
DOI: 10.1055/s-0038-1665283
Original Article
Schattauer GmbH Stuttgart

The Effect of Two Low Doses of Aspirin on Whole Blood Thromboxane and Prostacyclin Generation in Healthy Subjects

G Davì
The Institute of Clinical Medicine and Medical Pathology R, University of Palermo, Italy
,
N Custro
The Institute of Clinical Medicine and Medical Pathology R, University of Palermo, Italy
,
S Novo
The Institute of Clinical Medicine and Medical Pathology R, University of Palermo, Italy
,
A Mattina
The Institute of Clinical Medicine and Medical Pathology R, University of Palermo, Italy
,
A Strano
The Institute of Clinical Medicine and Medical Pathology R, University of Palermo, Italy
› Author Affiliations
Further Information

Publication History

Received 21 February 1983

Accepted 13 July 1983

Publication Date:
18 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The effects of two low doses of aspirin (20 mg and 100 mg) on prostacyclin and thromboxane formation during whole blood clotting were studied in 8 healthy volunteers.

A single 100 mg aspirin dose caused more than 90% reduction of both serum TXB2 and 6-keto-PGF1α; a single 20 mg dose of aspirin inhibited serum TXB2 more than 6-keto-PGF1α but effects on these two products could not be completely dissociated.

However, the effect of a single 20 mg aspirin dose on serum TXB2, was of much longer duration than its inhibitory effect on PGI2 synthesis during whole blood clotting.

Keywords

Thromboxane - Prostacyclin - Aspirin
 

  • References

  • 1 Roth GJ, Stanford N, Majerus PW. Acetylation of prostaglandin synthetase by aspirin. Proc Natl Acad Sci USA 1975; 72: 3073-3076
    CrossrefPubMedGoogle Scholar
  • 2 Hamberg M, Svensson J, Wakabayashi T, Samuelsson B. Isolation and structure of two prostaglandin that cause platelet aggregation. Proc Natl Acad Sci USA 1974; 71: 345-349
    CrossrefPubMedGoogle Scholar
  • 3 Kimberly RP, Gill JR, Bowden RE. Effects of aspirin on renal blood flow, glomerular filtration rate and renal prostaglandins in SLE. Arthritis Rheum 1977; 20: 123
    PubMedGoogle Scholar
  • 4 Child C, Jubiz W, Moore JG. Effects of aspirin on gastric prostaglandin E (PGE) and acid output in normal subjects. Gut 1976; 17: 54-57
    CrossrefPubMedGoogle Scholar
  • 5 Villa S, Calloni A, de Gaetano G. Normal prostacyclin-like activity in vascular tissue from thrombocytopenie rats. Thromb Res 1977; 11: 701-704
    CrossrefPubMedGoogle Scholar
  • 6 Wu KK, Chen YC, Fordnam E, Ts’ao CH, Rayudu G, Matayoshi D. Differential effects of two doses of aspirin on platelet-vessel wall interaction in vivo. J Clin Invest 1981; 68: 382-387
    CrossrefPubMedGoogle Scholar
  • 7 Preston FE, Whipps S, Jeckson CA, French AJ, Wyld PJ, Stoddard CJ. Inhibition of prostacyclin and platelet thromboxane A2 after low dose aspirin. N Engl J Med 1981; 304: 76-79
    CrossrefPubMedGoogle Scholar
  • 8 Hanley SP, Bevan J, Cockbill SR, Heptinstall S. Differential inhibition by low dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis. Lancet 1981; 1: 969-971
    PubMedGoogle Scholar
  • 9 Baenziger NL, Dillinder MJ, Majerus PW. Cultured human skin fibroblasts and arterial cells produced a labile platelet-inhibitory prostaglandin. Biochem Biophys Res Commun 1977; 78: 294-301
    CrossrefPubMedGoogle Scholar
  • 10 Patrono C, Ciabattoni G, Pinca E, Pugliese F, Castrucci G, De Salvo A, Satta MA, Peskar BA. Low dose aspirin and inhibition of thromboxane production in healthy subjects. Thromb Res 1980; 17: 317-327
    CrossrefPubMedGoogle Scholar
  • 11 Pareti FI, D’Angelo A, Mannucci PM, Smith JB. Platelets and the vessel wall: how much aspirin. Lancet 1980; 1: 371-372
    PubMedGoogle Scholar
  • 12 Mc Guire JC, Sun FF. Metabolism of arachidonic acid and prostaglandin endoperoxides by assorted leucocytes. In: Advances in Prostaglandin and Thromboxane Research. Samuelsson B, Ramwell PW, Paoletti R. (eds) Raven Press; New York: 1980. 8 1665
    Google Scholar
  • 13 Defreyn G, Deckmyn H, Vermylen J. A thromboxane synthetase ear inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2 . Thromb Res 1982; 26: 389-400
    CrossrefPubMedGoogle Scholar
  • 14 Vermylen J, Carreras LO, Vanchaeren J, Defreyn G, Maschin SY, Verstraete M. Thromboxane synthetase inhibition as antithrombotic strategy. Lancet 1981; 1: 1073-1075
    PubMedGoogle Scholar
  • 15 Strano A, Davì G, Avema M, Rini GB, Novo S, Di Fede G, Mattina A, Notarbartolo A. Platelet sensitivity to prostacyclin and thromboxane production in hyperlipidemic patients. Thromb Haemostas 1982; 48: 18-20
    PubMedGoogle Scholar
  • 16 Davì G, Orlandi M, Picone F, Galione G, Meringolo C, Mazzola A, Tomasi V, Capodicasa G, Strano A. Plasmatic TXB2 and 6-keto-PGF1α levels during charcoal hemoperfusion in chronic renal failure patients. Prostaglandins, Med 1983; 10: 309-315
    PubMedGoogle Scholar
  • 17 Blackwell GJ, Flower RJ, Russel-Smith N, Salmon JA, Thorogood PB, Vane JR. Prostacyclin is produced in whole blood. Br J Pharmacol 1978; 64: 436
    PubMedGoogle Scholar
  • 18 Parry MJ, Randall MJ, Tyler HM, Myhre E, Dale J, Thaulow E. elective inhibition of thromboxane synthetase by dazoxiben increase prostacyclin production by leucocytes in angina patients and healthy volunteers. Lancet 1982; 2: 164
    PubMedGoogle Scholar
  • 19 Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low dose aspirin in healthy subjects. J Clin Invest 1982; 69: 1366-1372
    CrossrefPubMedGoogle Scholar
  • 20 Viinikka L, Ylikorkala O. Effect of various doses of acetylsalicylic acid in combination with dipyridamole on the balance between prostacyclin and thromboxane in human serum. Br J Pharmacol 1981; 72: 299-303
    CrossrefPubMedGoogle Scholar
  • 21 Villa S, Livio M, de Gaetano G. The inhibitory effect of aspirin on platelet and vascular prostaglandins in rats cannot be completely dissociated. Br J Haematol 1979; 42: 425-431
    CrossrefPubMedGoogle Scholar
  • 22 Masotti G, Galanti G, Poggesi L, Abbate R, Neri Serneri GG. Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet 1979; 2: 1213-1216
    PubMedGoogle Scholar
  • 23 Burch JW, Stanford N, Majerus PW. Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest 1978; 61: 314-319
    CrossrefPubMedGoogle Scholar